Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTEUS: Prasugrel vs Ticagrelor De-escalation in NSTE-ACS
NCT05779059Phase 3Unknown
- Sponsor
- Collegium Medicum of Nicolaus Copernicus University in Bydgoszcz
- Start
- Apr 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of prasugrel, ticagrelor in non–ST-segment elevation acute coronary syndrome (NSTE-ACS), sponsored by Collegium Medicum of Nicolaus Copernicus University in Bydgoszcz. Status: unknown.
02
Drugs
prasugrelticagrelor
03
Conditions
non–ST-segment elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on NCT05779059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05779059.